Fingerprint Dive into the research topics where Scott H Kaufmann is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically
Medicine & Life Sciences
Apoptosis
Topotecan
Acute Myeloid Leukemia
Neoplasms
Type I DNA Topoisomerase
tipifarnib
irinotecan
Leukemia
Caspases
Cell Line
Ovarian Neoplasms
alvocidib
Etoposide
Camptothecin
Cell Death
Poly(ADP-ribose) Polymerases
Antineoplastic Agents
Cytarabine
Type II DNA Topoisomerase
Farnesyltranstransferase
NSC 680410
Proteins
Poisons
gemcitabine
Peptides
Carcinoma
Cisplatin
Pharmaceutical Preparations
Therapeutics
Drug Therapy
Nuclear Matrix
Peptide Hydrolases
Ligands
Breast Neoplasms
Platinum
Precursor Cell Lymphoblastic Leukemia-Lymphoma
DNA
Phosphotransferases
Phosphorylation
Mutation
Paclitaxel
Carboplatin
NSC 366140
Down-Regulation
Homologous Recombination
Noxae
Nuclear Envelope
HL-60 Cells
Lamin Type A
Topoisomerase I Inhibitors
Chemical Compounds
Apoptosis
Cells
Caspases
Chemical activation
Etoposide
Type I DNA Topoisomerase
NSC 680410
tipifarnib
irinotecan
Farnesyltranstransferase
Cytotoxicity
Peptides
Poisons
Cell death
DNA
Chemotherapy
Poly(ADP-ribose) Polymerases
Topotecan
Camptothecin
Proteins
Phosphorylation
Tumors
Genes
Death Domain Receptors
Ligands
Assays
Phosphotransferases
Tumor Necrosis Factor-alpha
Type II DNA Topoisomerase
Liver
Pharmacokinetics
Noxae
Caspase 3
Peptide Hydrolases
Bone
Paclitaxel
Rats
Antineoplastic Agents
Aspartic Acid
Pharmaceutical Preparations
Antibodies
Lamin Type A
Lamins
Sirolimus
Mitochondria
Degradation
Cytochromes c